Related references
Note: Only part of the references are listed.Rasagiline A Review of its Use in the Treatment of Idiopathic Parkinson's Disease
Sheridan M. Hoy et al.
DRUGS (2012)
Safety of rasagiline for the treatment of Parkinson's disease
Santiago Perez-Lloret et al.
EXPERT OPINION ON DRUG SAFETY (2011)
Rasagiline Time to Onset of Antiparkinson Effect is Similar When Used as a Monotherapy or Adjunct Treatment
Ronald E. Wilson et al.
NEUROLOGIST (2011)
Drug Therapies for Parkinson's Disease: A Database Analysis of Patient Compliance and Persistence
Marcy L. Tarrants et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2010)
How should we treat a patient with early Parkinson's disease?
S. Tsouli et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Long-term Outcome of Early Versus Delayed Rasagiline Treatment in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Safety of rasagiline in elderly patients with Parkinson disease
CG Goetz et al.
NEUROLOGY (2006)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol et al.
LANCET (2005)
Share Paper
